Gene · 84148
Papers2,655
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,655
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cavity Formation in Protein@Metal-Organic Frameworks Through Late-Stage Crystal Dissolution. | Small | 2026 | 42543893 | PubTator, text mining | PubMed |
| Discriminative Sensing of Structurally Similar Neurotransmitters via In-TBAPy MOF Arrays. | Nanomaterials (Basel) | 2026 | 42506524 | PubTator, text mining | PubMed |
| An Ultramicroporous MOF with Abundant Accessible Binding Sites for Separating MTO Products. | Inorg Chem | 2026 | 42504505 | PubTator, text mining | PubMed |
| KAT8-mediated epigenetic modifications: Physiological functions, heterogeneity in disease, and advances in targeted development. | iScience | 2026 | 42472105 | PubTator, text mining | PubMed |
| Author Correction: Disrupting the phase separation of KAT8-IRF1 diminishes PD-L1 expression and promotes antitumor immunity. | Nat Cancer | 2026 | 42463860 | PubTator, text mining | PubMed |
| Vanadium Cation Exchange-Driven Reconstruction of MOF-Derived Cobalt Hydroxide Electrodes for Electrocatalysis and Energy Storage. | Adv Sci (Weinh) | 2026 | 42446147 | PubTator, text mining | PubMed |
| Efficient screening for enhanced Xe/Kr separation via fixed-ligand, variable-metal strategy in metal-organic frameworks. | RSC Adv | 2026 | 42395816 | PubTator, text mining | PubMed |
| HDAC1-mediated CDK1 decrotonylation inhibits colorectal cancer proliferation by regulating cell cycle and apoptosis. | Front Oncol | 2026 | 42382394 | PubTator, text mining | PubMed |
| Lactate-Driven Restriction of Mitochondrial Permeability Transition Promotes Resistance to Chemo-Immunotherapy by Suppressing Tumor PANoptosis. | Adv Sci (Weinh) | 2026 | 42378634 | PubTator, text mining | PubMed |
| Integrated Machine Learning with Molecular Simulation for Screening MOF Adsorbents toward High-Performance Separation of CO2/CH4. | ACS Omega | 2026 | 42368136 | PubTator, text mining | PubMed |
| A Dual-Site Functional MOF Engineered for Effective Degradation of Polycyclic Aromatic Hydrocarbons Through Photo-Induced Oxidants Regeneration. | Small | 2026 | 42335342 | PubTator, text mining | PubMed |
| Bimetallic-Node-Occupied MOF With Glycoside Hydrolase Activity for Efficient Bacterial Biofilm Hydrolysis. | Angew Chem Int Ed Engl | 2026 | 42333880 | PubTator, text mining | PubMed |
| Lactate as a Chemical Modification on Proteins and Metabolites. | Annu Rev Biochem | 2026 | 42331744 | PubTator, text mining | PubMed |
| SIRT2 antagonizes MOF function during mitotic entry. | Sci Adv | 2026 | 42319919 | PubTator, text mining | PubMed |
| Impact of Linker Defects on the Dielectric Properties of the Metal-Organic Framework HKUST-1: Insights from Molecular Dynamics Simulations. | ACS Appl Mater Interfaces | 2026 | 42319231 | PubTator, text mining | PubMed |
| Amino Acid-Programmed Biomineralization for Radical-Proximal Enzyme-MOF Interfaces in Electrochemiluminescent Influenza Hemagglutinin Sensing. | Anal Chem | 2026 | 42287620 | PubTator, text mining | PubMed |
| Interpretable Machine Learning Unveils Hydroxyl/Amino Synergy and Guides Discovery of Optimal MOF Photocatalysts for Hydrogen Evolution. | J Am Chem Soc | 2026 | 42287214 | PubTator, text mining | PubMed |
| Use of the MOF NU-1000 as a Drug Delivery System for the Antineoplastic Drug Mitoxantrone. | Int J Mol Sci | 2026 | 42278387 | PubTator, text mining | PubMed |
| Engineering CO2 Pre-Activation in In-MOF for Enhancing its Electroreduction Activity. | Small | 2026 | 42274028 | PubTator, text mining | PubMed |
| Mechanistic Understanding of Protein-MOF Integration Through Surfactant-Driven Interfacial Design. | Adv Sci (Weinh) | 2026 | 42261836 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84148/papers?page=2